202 related articles for article (PubMed ID: 12675696)
21. Risk stratification for the prevention of cardiovascular complications of hypertension.
Girerd X; Giral P
Curr Med Res Opin; 2004 Jul; 20(7):1137-42. PubMed ID: 15265258
[TBL] [Abstract][Full Text] [Related]
22. Goals of antihypertensive therapy.
McVeigh GE; Flack J; Grimm R
Drugs; 1995 Feb; 49(2):161-75. PubMed ID: 7729325
[TBL] [Abstract][Full Text] [Related]
23. [Blood pressure lowering therapy for mild hypertensive patients with a history of stroke].
Ishikawa E; Ibayashi S
Nihon Rinsho; 2008 Aug; 66(8):1560-5. PubMed ID: 18700558
[TBL] [Abstract][Full Text] [Related]
24. The role of angiotensin II type 1 receptor antagonists in elderly patients with hypertension.
Thomas GN; Chan P; Tomlinson B
Drugs Aging; 2006; 23(2):131-55. PubMed ID: 16536636
[TBL] [Abstract][Full Text] [Related]
25. Effects of blood pressure-lowering treatment on cardiovascular outcomes and mortality: 14 - effects of different classes of antihypertensive drugs in older and younger patients: overview and meta-analysis.
Thomopoulos C; Parati G; Zanchetti A
J Hypertens; 2018 Aug; 36(8):1637-1647. PubMed ID: 29847487
[TBL] [Abstract][Full Text] [Related]
26. Baseline characteristics of the diabetic participants in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Barzilay JI; Jones CL; Davis BR; Basile JN; Goff DC; Ciocon JO; Sweeney ME; Randall OS;
Diabetes Care; 2001 Apr; 24(4):654-8. PubMed ID: 11315826
[TBL] [Abstract][Full Text] [Related]
27. Role of antihypertensive therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers in combination with calcium channel blockers for stroke prevention.
Talbert RL
J Am Pharm Assoc (2003); 2010; 50(5):e116-25. PubMed ID: 20833609
[TBL] [Abstract][Full Text] [Related]
28. Vascular changes in hypertension in response to drug treatment: Effects of angiotensin receptor blockers.
Schiffrin EL
Can J Cardiol; 2002 May; 18 Suppl A():15A-18A. PubMed ID: 12045789
[TBL] [Abstract][Full Text] [Related]
29. Blood pressure treatment levels and choice of antihypertensive agent in people with diabetes mellitus: an overview of systematic reviews.
Brunström M; Eliasson M; Nilsson PM; Carlberg B
J Hypertens; 2017 Mar; 35(3):453-462. PubMed ID: 27870655
[TBL] [Abstract][Full Text] [Related]
30. [Antihypertensive treatment for patients with hypertension and diabetes type II--current clinical research].
Rajzer M; Kawecka-Jaszcz K; Wojciechowska W
Przegl Lek; 2003; 60(2):111-5. PubMed ID: 12939858
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of Zofenopril vs. Irbesartan in Combination with a Thiazide Diuretic in Hypertensive Patients with Multiple Risk Factors not Controlled by a Previous Monotherapy: A Review of the Double-Blind, Randomized "Z" Studies.
Omboni S; Malacco E; Napoli C; Modesti PA; Manolis A; Parati G; Agabiti-Rosei E; Borghi C
Adv Ther; 2017 Apr; 34(4):784-798. PubMed ID: 28260186
[TBL] [Abstract][Full Text] [Related]
32. New treatment guidelines for a patient with diabetes and hypertension.
Mogensen CE
J Hypertens Suppl; 2003 Mar; 21(1):S25-30. PubMed ID: 12769164
[TBL] [Abstract][Full Text] [Related]
33. Stroke in chronic kidney disease: prevention and management.
Townsend RR
Clin J Am Soc Nephrol; 2008 Jan; 3 Suppl 1(Suppl 1):S11-6. PubMed ID: 18178791
[TBL] [Abstract][Full Text] [Related]
34. [Control of arterial hypertension in stroke prevention].
Britov AN; Bystrova MM; Orlov AA
Klin Med (Mosk); 2002; 80(6):53-7. PubMed ID: 12138805
[TBL] [Abstract][Full Text] [Related]
35. [Practice of antihypertensive treatment in diabetic patients with hypertension in Hungary].
Szentes V; Kovács G; Dézsi CA
Orv Hetil; 2014 Oct; 155(43):1695-700. PubMed ID: 25327459
[TBL] [Abstract][Full Text] [Related]
36. Antihypertensive and lipid lowering treatment in stroke prevention: current state and future.
Piechowski-Jóźwiak B; Bogousslavsky J
Acta Neurol Belg; 2005 Jun; 105(2):57-61. PubMed ID: 16076057
[TBL] [Abstract][Full Text] [Related]
37. Angiotensin-Converting Enzyme Inhibitors in Hypertension: To Use or Not to Use?
Messerli FH; Bangalore S; Bavishi C; Rimoldi SF
J Am Coll Cardiol; 2018 Apr; 71(13):1474-1482. PubMed ID: 29598869
[TBL] [Abstract][Full Text] [Related]
38. Higher small arterial elasticity in hypertensive patients treated with angiotensin II receptor blockers.
Takeuchi K; Ideishi M; Tashiro T; Morishige N; Yamada T; Saku K; Urata H
Hypertens Res; 2005 Aug; 28(8):639-44. PubMed ID: 16392767
[TBL] [Abstract][Full Text] [Related]
39. Treatment of arterial remodeling in essential hypertension.
Briet M; Schiffrin EL
Curr Hypertens Rep; 2013 Feb; 15(1):3-9. PubMed ID: 23250721
[TBL] [Abstract][Full Text] [Related]
40. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
